Androgen receptor, Internal medicine, Selective androgen receptor modulator, Pharmacology and Endocrinology are his primary areas of study. His research in Androgen receptor intersects with topics in Testosterone, Androgen, Dihydrotestosterone and Agonist. His study in the fields of Sarcopenia, Cachexia and Prostate cancer under the domain of Internal medicine overlaps with other disciplines such as Lean body mass.
His Selective androgen receptor modulator study combines topics in areas such as Osteoporosis and Skeletal muscle. His Pharmacology research incorporates elements of Receptor, Androgen Therapy, In vivo and Prostate. His study looks at the relationship between Endocrinology and fields such as Estrogen receptor, as well as how they intersect with chemical problems.
James T. Dalton spends much of his time researching Internal medicine, Androgen receptor, Pharmacology, Endocrinology and Prostate cancer. In his research on the topic of Internal medicine, Tumor lysis syndrome and Chronic lymphocytic leukemia is strongly related with Oncology. James T. Dalton is studying Selective androgen receptor modulator, which is a component of Androgen receptor.
His Pharmacology research incorporates themes from Metabolite, Cancer and In vivo. In the field of Endocrinology, his study on Testosterone, Osteopenia and Estrogen overlaps with subjects such as Lean body mass. His research investigates the connection with Prostate cancer and areas like Cancer research which intersect with concerns in LNCaP, Breast cancer and Cytotoxicity.
His primary areas of investigation include Cancer research, Androgen receptor, Internal medicine, Prostate cancer and Breast cancer. His Androgen receptor study incorporates themes from Bioinformatics, Halogen, Receptor, Clinical endpoint and Pharmacology. His work carried out in the field of Pharmacology brings together such families of science as Fibrosis and Obesity.
The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine. His Prostate cancer research is multidisciplinary, relying on both Tubulin, Amyotrophic lateral sclerosis, Paclitaxel and Urology. His studies in Breast cancer integrate themes in fields like AR Positive and Selective androgen receptor modulator.
The scientist’s investigation covers issues in Androgen receptor, Internal medicine, Cancer research, Cancer and Receptor. His Androgen receptor study results in a more complete grasp of Prostate cancer. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
His Endocrinology study combines topics in areas such as Steroid hormone receptor and Amyotrophic lateral sclerosis. His studies examine the connections between Cancer research and genetics, as well as such issues in Androgen, with regards to Agonist, Antagonist, Aromatase and Indazole. He has researched Cancer in several fields, including Osteosarcoma, Somatic cell, Pharmacology and Mechanism of action.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan;Christopher B. Miller;Ina Radtke;Letha A. Phillips.
Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations
Margaret C. Thompson;Christine Fuller;Twala L. Hogg;James Dalton.
Journal of Clinical Oncology (2006)
Chemistry and structural biology of androgen receptor
Wenqing Gao;Casey E. Bohl;James T. Dalton.
Chemical Reviews (2005)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen;Armita Bahrami;Alberto Pappo;John Easton.
Cell Reports (2014)
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.
John C. Byrd;Thomas S. Lin;James T. Dalton;Di Wu.
Structural basis for antagonism and resistance of bicalutamide in prostate cancer.
Casey E. Bohl;Wenqing Gao;Duane D. Miller;Charles E. Bell.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy
Tanya M. Tekautz;Christine E. Fuller;Susan Blaney;Maryam Fouladi.
Journal of Clinical Oncology (2005)
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation
Africa Fernandez-L;Paul A. Northcott;James Dalton;Charles Fraga.
Genes & Development (2009)
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung;Jinghui Zhang;Charles Lu;Matthew Parker.
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
James T. Dalton;Kester G. Barnette;Casey E. Bohl;Michael L. Hancock.
Journal of Cachexia, Sarcopenia and Muscle (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: